These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8494009)

  • 1. Morbidity and mortality due to hypertension in patients with renal failure.
    Ritz E; Koch M
    Am J Kidney Dis; 1993 May; 21(5 Suppl 2):113-8. PubMed ID: 8494009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of hypertension in renal failure patients: when do we overtreat? When do we undertreat?
    Rosansky SJ
    Blood Purif; 1996; 14(4):315-20. PubMed ID: 8873957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cardioprotection: an essential component for predialysis chronic renal failure treatment].
    Jungers P; Qualim Z; Nguyen-Khoa T; Massy Z; London G
    Nephrologie; 2003; 24(2):79-88. PubMed ID: 12723513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular factors influencing survival in dialysis patients.
    Alpert MA
    Adv Perit Dial; 1996; 12():110-9. PubMed ID: 8865884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left ventricular hypertrophy is a risk factor independent of hypertension in survival of hemodialyzed patients.
    Nakamura S; Sasaki O; Nakahama H; Inenaga T; Kimura G
    Ren Fail; 2002 Mar; 24(2):175-86. PubMed ID: 12071591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodialysis-associated hypertension: pathophysiology and therapy.
    Hörl MP; Hörl WH
    Am J Kidney Dis; 2002 Feb; 39(2):227-44. PubMed ID: 11840363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertension and survival in chronic hemodialysis patients--past lessons and future opportunities.
    Agarwal R
    Kidney Int; 2005 Jan; 67(1):1-13. PubMed ID: 15610223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensive Hemodialysis, Left Ventricular Hypertrophy, and Cardiovascular Disease.
    McCullough PA; Chan CT; Weinhandl ED; Burkart JM; Bakris GL
    Am J Kidney Dis; 2016 Nov; 68(5S1):S5-S14. PubMed ID: 27772643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is hypertension a mortality risk factor in dialysis?
    Duranti E; Imperiali P; Sasdelli M
    Kidney Int Suppl; 1996 Jun; 55():S173-4. PubMed ID: 8743547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of hypertension on cardiovascular outcomes in hemodialysis patients.
    Birchem JA; Fraley MA; Senkottaiyan N; Alpert MA
    Semin Dial; 2005; 18(5):391-5. PubMed ID: 16191179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular complications in renal failure.
    Rostand SG; Brunzell JD; Cannon RO; Victor RG
    J Am Soc Nephrol; 1991 Dec; 2(6):1053-62. PubMed ID: 1777585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Kidney insufficiency and cardiovascular disease].
    Weidtmann B; Schunkert H
    Internist (Berl); 2007 Aug; 48(8):770-8. PubMed ID: 17628763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baroreflex effectiveness index and baroreflex sensitivity predict all-cause mortality and sudden death in hypertensive patients with chronic renal failure.
    Johansson M; Gao SA; Friberg P; Annerstedt M; Carlström J; Ivarsson T; Jensen G; Ljungman S; Mathillas O; Nielsen FD; Strömbom U
    J Hypertens; 2007 Jan; 25(1):163-8. PubMed ID: 17143188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis.
    Klassen PS; Lowrie EG; Reddan DN; DeLong ER; Coladonato JA; Szczech LA; Lazarus JM; Owen WF
    JAMA; 2002 Mar; 287(12):1548-55. PubMed ID: 11911757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-dipping is a potent predictor of cardiovascular mortality and is associated with autonomic dysfunction in haemodialysis patients.
    Liu M; Takahashi H; Morita Y; Maruyama S; Mizuno M; Yuzawa Y; Watanabe M; Toriyama T; Kawahara H; Matsuo S
    Nephrol Dial Transplant; 2003 Mar; 18(3):563-9. PubMed ID: 12584280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac consequences of hypertension in hemodialysis patients.
    Zoccali C; Benedetto FA; Tripepi G; Mallamaci F
    Semin Dial; 2004; 17(4):299-303. PubMed ID: 15250922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cardiovascular diseases in patients with chronic renal diseases].
    Dimković N
    Srp Arh Celok Lek; 2008 May; 136 Suppl 2():135-41. PubMed ID: 18924484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predialysis management and predictors for early mortality in uremic patients who die within one year after initiation of dialysis therapy.
    Biesenbach G; Hubmann R; Janko O; Schmekal B; Eichbauer-Sturm G
    Ren Fail; 2002 Mar; 24(2):197-205. PubMed ID: 12071593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood pressure and cardiovascular mortality in dialysis patients with left ventricular systolic dysfunction.
    Losito A; Del Vecchio L; Del Rosso G; Malandra R;
    Am J Hypertens; 2014 Mar; 27(3):401-8. PubMed ID: 24108864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease.
    Foley RN; Parfrey PS; Harnett JD; Kent GM; Murray DC; Barre PE
    Kidney Int; 1996 May; 49(5):1379-85. PubMed ID: 8731103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.